The transient receptor potential Ankyrin 1 (TRPA1) cation channel is activated by various pungent and irritant compounds, and it also mediates the perception of noxious cold. Identification of different agonists for this channel is important for understanding its activation mechanism. Therefore, a screen for novel TRPA1 agonists was performed using an agonist-induced calcium influx assay. Out of 90 compounds screened, pinacidil was identified as a novel agonist for this channel. Pinacidil is a known opener of the K atp channel, for which it has an EC 50 value of 1-3 μmol/L. In comparison, the EC 50 value of pinacidil for TRPA1 is relatively high (260 μmol/L). Recombinant HEK-TRPA1 cells did not respond to P1075, another K atp channel opener, suggesting that the effect of pinacidil on TRPA1 was highly specific. Further studies revealed that the agonist activity of pinacidil could be blocked by the TRP channel inhibitors, ruthenium red and HC-030031. Using glutathione (GSH) and site-specific mutagenesis, we demonstrated that pinacidil could activate TRPA1 by covalent modification of the critical amino acids C619, C639 and C663 in the N-terminus of TRPA1.
TRPA1, pinacidil, covalent modification
Citation:Ma L H, Deng Y, Zhang B, et al. Pinacidil, a K atp channel opener, identified as a novel agonist for TRPA1.